source
- STAT+: FTC settles lawsuit with CVS Caremark over charges it manipulated insulin prices, impeded accessThe FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.STAT · 15d ago↗ source
- CVS Caremark reaches settlement with FTC over insulin suitTerms of the deal announced Tuesday are very similar to those the FTC reached with Express Scripts earlier this year, including requiring the PBM to stop preferring higher cost versions of drugs on…BioPharma Dive · 15d ago↗ source
- STAT+: Sales from controversial U.S. drug discount program rose to $100 billion last yearPrescription drugs purchased under a controversial government discount program amounted to $100 billion in 2025, a 22.8% increase from the previous year.